Effects of Dalfampridine on Cognition in Multiple Sclerosis
Clinical trial NCT02006160 · COMPLETED
Trial details
- NCT number
- NCT02006160
- Sponsor
- State University of New York at Buffalo
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.